Aptamers in Neuroscience
10 October 2016
Our attention this week turns to how aptamers can be utilised to conduct research into the prevention and treatment of neurodegenerative diseases. In this whitepaper, we present recent advances in aptamer generation discussing merits and limitations. Emphasis is placed on applications for diseases including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis and other diseases stemming from protein aggregation.